Terms: = Breast cancer AND LYL1, P12980, 4066, ENSG00000104903 AND Clinical Outcome
2 results:
1. Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline
Somlo G; Frankel PH; Arun BK; Ma CX; Garcia AA; Cigler T; Cream LV; Harvey HA; Sparano JA; Nanda R; Chew HK; Moynihan TJ; Vahdat LT; Goetz MP; Beumer JH; Hurria A; Mortimer J; Piekarz R; Sand S; Herzog J; Van Tongeren LR; Ferry-Galow KV; Chen AP; Ruel C; Newman EM; Gandara DR; Weitzel JN
Clin Cancer Res; 2017 Aug; 23(15):4066-4076. PubMed ID: 28356425
[No Abstract] [Full Text] [Related]
2. High-dose chemotherapy and autologous stem cell transplant in women with de novo chemosensitive metastatic breast cancer.
Stemmer SM; Hardan I; Brenner HJ; Rizel S
Am J Clin Oncol; 2004 Jun; 27(3):250-5. PubMed ID: 15170143
[TBL] [Abstract] [Full Text] [Related]
